By BMI – body mass index – is the most widely used measure of body size in medicine and public health. It’s on your medical records, it’s used to classify obesity and health risk in clinical guidelines, and it’s the basis of most large-scale epidemiological research on body weight and health. It’s also one of the most consistently criticized metrics in clinical medicine.
Both the criticism and the defense of BMI are partly right. Understanding what BMI actually measures, where its limitations are most serious, and what alternative or supplementary measures provide better information is more useful than either dismissing it entirely or treating it as the definitive measure of health.
What BMI Is and Where It Came From
Body mass index is calculated as weight in kilograms divided by height in meters squared (kg/m²). In US units: weight in pounds multiplied by 703, divided by height in inches squared.
The current BMI classification system used in the US:
| BMI | Category |
|---|---|
| Below 18.5 | Underweight |
| 18.5 – 24.9 | Normal weight |
| 25.0 – 29.9 | Overweight |
| 30.0 – 34.9 | Obesity Class I |
| 35.0 – 39.9 | Obesity Class II |
| 40.0 and above | Obesity Class III (severe obesity) |
BMI was developed by Belgian mathematician Adolphe Quetelet in the 1830s as a statistical description of population body size – not as an individual health assessment tool. It was adopted into medical practice in the 1970s-1980s as a practical proxy for body fatness because it’s simple to calculate, requires no equipment, and correlates reasonably well with body fat percentage at the population level.
The current obesity thresholds were set in 1998 by the National Institutes of Health, partly based on epidemiological evidence linking higher BMI with adverse health outcomes. This was somewhat arbitrary – the cut-points moved overnight and millions of Americans suddenly became “overweight” without gaining a pound.
What BMI Measures – and What It Doesn’t
BMI measures the ratio of weight to height squared. That’s it. It doesn’t measure body fat directly, it doesn’t distinguish fat from muscle, it doesn’t measure fat distribution (where fat is located in the body), and it doesn’t measure any metabolic parameter.
This matters because two people with identical BMIs can have profoundly different body compositions and health profiles:
Example 1: A 6’0″ male athlete at 220 lbs (BMI 29.8 – “overweight”) with 15% body fat and excellent cardiovascular fitness. His high BMI reflects substantial muscle mass, not excess fat.
Example 2: A sedentary 6’0″ male at 220 lbs (BMI 29.8) with 28% body fat, elevated visceral adiposity, and borderline metabolic markers. Same BMI, very different health picture.
BMI treats both of these people as equivalent. In clinical risk assessment, they’re not.
The Muscle Mass Problem
Skeletal muscle is denser and heavier than fat tissue. People with high muscle mass – strength athletes, bodybuilders, even regularly resistance-trained individuals – frequently have BMIs in the “overweight” or even “obese” range despite low body fat percentages and excellent metabolic health.
This is BMI’s most obvious limitation. When someone is visibly muscular and athletic, a high BMI clearly misclassifies their health risk. Most primary care physicians recognize this and adjust their assessment accordingly – but the classification still ends up in medical records and insurance systems where nuance is lost.
The “Normal Weight Obesity” Problem
The more clinically significant limitation runs in the opposite direction. Some people with “normal” BMIs (18.5-24.9) have high body fat percentages and significant visceral adiposity – enough to carry meaningful metabolic risk. This is called “normal weight obesity” or TOFI (Thin Outside, Fat Inside).
Research has found that up to 20-30% of normal-BMI adults have metabolic profiles that resemble obesity – elevated visceral fat, insulin resistance, dyslipidemia – when assessed with more sensitive measures. These individuals are misclassified as low-risk by BMI alone.
This is arguably more problematic than misclassifying muscular people as overweight, because it creates false reassurance in people who may have significant undetected metabolic risk.
The Ethnic Variation Problem
The current BMI thresholds were derived primarily from studies of European populations. Evidence consistently shows that people of Asian descent develop metabolic complications (type 2 diabetes, cardiovascular disease, hypertension) at lower BMIs than Europeans.
The World Health Organization and multiple national guidelines recommend lower BMI action points for South Asian and East Asian populations – typically obesity thresholds of 25-27.5 kg/m² rather than 30 kg/m². The ADA recommends diabetes screening for Asian Americans at BMI 23+.
Using standard BMI cutoffs in Asian patients systematically underestimates metabolic risk and delays appropriate screening and intervention.
Conversely, some research suggests Black Americans may have lower metabolic risk at a given BMI compared to white Americans of similar BMI – though cardiovascular and hypertension risk patterns still warrant careful monitoring.
What BMI Is Actually Useful For
Despite its limitations, BMI is not useless. It has genuine utility in specific contexts:
Population-level epidemiology: At the population scale, BMI correlates reasonably well with average body fatness and with health outcome data. This is why it remains the standard measure in large studies examining weight-health relationships.
Tracking trends over time in an individual: For someone not at the extremes of muscle mass or very tall/very short, changes in BMI over years reflect real changes in body composition. A BMI rising from 24 to 28 over 5 years is a meaningful signal regardless of BMI’s absolute limitations.
Initial screening trigger: A high BMI, even with its limitations, appropriately flags the need for further metabolic assessment – blood pressure, glucose, lipids, waist circumference. It’s a reasonable starting point, not a final answer.
Clinical trial eligibility and dosing: Many clinical trials and medication dosing calculations use BMI because it’s universally available and consistently measured. This makes it practically necessary for comparing research results.
Better Measures: What Should Replace or Supplement BMI
Waist Circumference
Waist circumference directly measures abdominal size, which correlates much more strongly with visceral adiposity than BMI. High waist circumference is a direct marker of the fat depot most responsible for metabolic risk.
Measurement: At the level of the navel, relaxed (not held in), at end of normal exhalation. Use a flexible tape measure.
Elevated thresholds (major metabolic syndrome criteria):
- Men: above 40 inches (102 cm)
- Women: above 35 inches (88 cm)
- South and East Asian men: above 35-36 inches; women: above 31-32 inches
Waist circumference is the single most practical improvement over BMI for clinical metabolic risk assessment and is already incorporated into metabolic syndrome diagnostic criteria.
Waist-to-Height Ratio
Waist circumference divided by height in the same units. Proposed threshold of above 0.5 as a risk indicator – meaning your waist should be less than half your height.
Waist-to-height ratio has several advantages over both BMI and raw waist circumference: it adjusts for body size (taller people naturally have larger waists), it performs well across different ethnic groups, and it has strong evidence linking it to cardiovascular and metabolic outcomes.
Some evidence suggests waist-to-height ratio outperforms BMI as a predictor of cardiovascular events and mortality. It’s simple, requires no special equipment, and avoids the ethnic calibration problems of BMI.
Body Composition Measurement
Direct measurement of fat mass vs lean mass provides the most accurate body composition picture. Methods include:
DEXA (dual-energy X-ray absorptiometry): The gold standard for body composition, measuring fat, lean mass, and bone density simultaneously. Used clinically for osteoporosis screening; increasingly available for body composition analysis. Relatively expensive and requires specialized equipment.
Bioelectrical impedance analysis (BIA): Passes a low-level electrical current through the body and estimates fat vs lean mass based on impedance differences. Available in consumer scales and clinical devices. Results vary significantly with hydration status, time of day, and device quality. Modern multi-frequency BIA scales can be reasonably accurate.
Hydrostatic weighing: Weighing underwater. Highly accurate but impractical for routine clinical use.
Skinfold measurements: Calipers measuring skin fold thickness at multiple sites. Accurate when done by experienced practitioners; less reliable otherwise.
For clinical and personal use, BIA provides a practical body fat percentage estimate. A high-quality BIA scale ($30-100) measured consistently at the same time of day and hydration state gives useful data for tracking trends over time.
Metabolic Markers (The Most Important Supplement to BMI)
Ultimately, the most clinically meaningful way to assess health risk in people with high or borderline BMI is through metabolic markers: blood pressure, fasting glucose/HbA1c, fasting lipid panel (particularly triglycerides and HDL), and waist circumference.
A person with BMI 31 and normal blood pressure, normal glucose, normal lipids, and normal waist circumference has very different cardiovascular and metabolic risk than a person with BMI 28 and elevated blood pressure, borderline glucose, elevated triglycerides, and high waist circumference. BMI alone cannot distinguish these people. Metabolic markers can.
This is sometimes called the “metabolically healthy obese” vs “metabolically unhealthy normal weight” distinction – and it’s clinically real, even though there’s debate about how stable “metabolically healthy obesity” is over the long term.
The AMA’s 2023 Position on BMI
In a significant policy shift, the American Medical Association adopted a new policy in June 2023 acknowledging BMI’s limitations as a health measure – specifically its failure to account for body composition, racial and ethnic differences, and its inability to capture metabolic health.
The AMA’s position: BMI should not be used alone as a clinical measure of health or as a basis for denying coverage or care. The organization called for additional measures alongside BMI, including waist circumference, body composition, and direct metabolic assessment.
This represents a meaningful institutional shift in how the medical community is moving away from BMI as a standalone health proxy.
Frequently Asked Questions
Should I ignore my BMI entirely? Not entirely – but don’t treat it as the final word. A high BMI is a signal to assess metabolic markers more carefully, not a diagnosis. A normal BMI is not a guarantee of good metabolic health. Use BMI as one data point alongside waist circumference, blood pressure, blood glucose, and lipids.
My BMI is 27 but I exercise regularly and feel healthy. Do I need to worry? A BMI of 27 in an active person with normal waist circumference and normal metabolic markers carries very low risk. If your blood pressure, glucose, triglycerides, and HDL are all in healthy ranges and your waist circumference is below threshold, the BMI number alone is not a meaningful concern.
Why do doctors still use BMI if it’s so flawed? Primarily because it’s simple, universal, requires no equipment, and has decades of population-level research behind it. Its correlation with health outcomes at the population level is real, even if it misclassifies individuals. As more accurate and accessible alternatives become standard practice, BMI’s role should diminish – and the AMA’s 2023 position reflects this direction.
What body fat percentage is healthy? General healthy body fat percentage ranges (these vary by source and population):
- Men: 10-20% is generally considered healthy; 20-25% borderline; above 25% elevated risk
- Women: 18-28% generally healthy; 28-35% borderline; above 35% elevated risk These are approximate. Body fat distribution (where fat is located) matters as much as percentage.
Is BMI accurate for very tall or very short people? No – height has a non-linear relationship with weight in the population, which the BMI formula doesn’t fully capture. Very tall people tend to have slightly elevated BMIs even at healthy weight; very short people tend to have slightly lower BMIs. This is a known mathematical artifact of the formula.
Disclaimer
This article is for educational purposes only and does not constitute medical advice. Health risk assessment should be individualized with a qualified healthcare provider who can consider your complete clinical picture, not BMI alone.
References
- American Medical Association. AMA adopts new policy clarifying role of BMI as a measure in medicine. June 2023. https://www.ama-assn.org/press-center/press-releases/ama-adopts-new-policy-clarifying-role-bmi-measure-medicine
- Nuttall FQ. Body mass index: obesity, BMI, and health – a critical review. Nutrition Today. 2015;50(3):117-128. https://doi.org/10.1097/NT.0000000000000092
- World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva: WHO; 2008. https://www.who.int/publications/i/item/9789241501491
- Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors. Obesity Reviews. 2012;13(3):275-286. https://doi.org/10.1111/j.1467-789X.2011.00952.x
- Heymsfield SB, Peterson CM, Thomas DM, Heo M, Schuna JM. Why are there race/ethnic differences in adult body mass index-adiposity relationships? Current Opinion in Clinical Nutrition and Metabolic Care. 2016;19(4):269-279. https://doi.org/10.1097/MCO.0000000000000296
- Tomiyama AJ, Hunger JM, Nguyen-Cuu J, Wells C. Misclassification of cardiometabolic health when using body mass index categories in NHANES 2005-2012. International Journal of Obesity. 2016;40(5):883-886. https://doi.org/10.1038/ijo.2016.17
- National Heart, Lung, and Blood Institute (NHLBI). Calculate your body mass index. https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm
- Centers for Disease Control and Prevention (CDC). About adult BMI. https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html
- Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. The Lancet Diabetes & Endocrinology. 2013;1(2):152-162. https://doi.org/10.1016/S2213-8587(13)70062-7
- Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301-1313. https://doi.org/10.1161/CIRCULATIONAHA.111.067264
